I agree that this site is using cookies. You can find further informations here.
X
DiBernardo, Allitia
80  results:
Search for persons X
?
1

Analysis and Evaluation of Ponesimod Hepatic Safety Data (P..:

Vaclavkova, Andrea ; Walter, Verena ; DiBernardo, Allitia.
Neurology.  98 (2022)  18_supplement - p. , 2022
Link: https://doi.org/10.1212/..
 
?
2

Ponesimod Shows Improved Effect on Brain Volume Compared wi..:

Ait-Tihyaty, Maria ; Zierhut, Matthew ; Keenan, Alexander.
Neurology.  98 (2022)  18_supplement - p. , 2022
Link: https://doi.org/10.1212/..
 
?
3

Montgomery‐Åsberg Depression Rating Scale factors in treatm..:

Borentain, Stephane ; Gogate, Jagadish ; Williamson, David...
International Journal of Methods in Psychiatric Research.  31 (2022)  4 - p. , 2022
Link: https://doi.org/10.1002/..
 
?
4

Accurate prediction of clinical stroke scales and improved ..:

Agrafiotis, Dimitris K. ; Yang, Eric ; Littman, Gary S....
PLOS ONE.  16 (2021)  1 - p. e0245874 , 2021
Link: https://doi.org/10.1371/..
 
?
5

Appraising esketamine nasal spray for the management of tre..:

Citrome, Leslie ; DiBernardo, Allitia ; Singh, Jaskaran
Journal of Affective Disorders.  271 (2020)  - p. 228-238 , 2020
Link: https://doi.org/10.1016/..
 
?
6

Patient-reported outcomes in major depressive disorder with..:

Borentain, Stephane ; Nash, Abigail I. ; Dayal, Rachna.
BMC Psychiatry.  20 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
7

A retrospective analysis to estimate the healthcare resourc..:

Li, Gang ; Zhang, Ling ; DiBernardo, Allitia...
PLOS ONE.  15 (2020)  9 - p. e0238843 , 2020
Link: https://doi.org/10.1371/..
 
?
8

Risk and risk factors for disability pension among patients..:

Taipale, Heidi ; Reutfors, Johan ; Tanskanen, Antti...
BMC Psychiatry.  20 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
9

142 Withdrawal Symptom Assessment in an Esketamine Safety S..:

Aluisio, Leah ; Yieh, Lynn ; Wajs, Ewa...
CNS Spectrums.  25 (2020)  2 - p. 290-290 , 2020
Link: https://doi.org/10.1017/..
 
?
10

Patient preferences for ketamine-based antidepressant treat..:

Fairchild, Angelyn O. ; Katz, Eva G. ; Reed, Shelby D....
Neurology, Psychiatry and Brain Research.  37 (2020)  - p. 67-78 , 2020
Link: https://doi.org/10.1016/..
 
?
11

A register-based approach to identifying treatment-resistan..:

Hägg, David ; Brenner, Philip ; Reutfors, Johan...
PLOS ONE.  15 (2020)  7 - p. e0236434 , 2020
Link: https://doi.org/10.1371/..
 
?
12

144 Esketamine Nasal Spray for Management of Treatment-Resi..:

Citrome, Leslie ; DiBernardo, Allitia ; Singh, Jaskaran
CNS Spectrums.  25 (2020)  2 - p. 291-292 , 2020
Link: https://doi.org/10.1017/..
 
?
13

Managing Esketamine Treatment Frequency Toward Successful O..:

Nijs, Michel ; Wajs, Ewa ; Aluisio, Leah...
International Journal of Neuropsychopharmacology.  23 (2020)  7 - p. 426-433 , 2020
Link: https://doi.org/10.1093/..
 
?
14

Substance use disorders and risk for treatment resistant de..:

Brenner, Philip ; Brandt, Lena ; Li, Gang...
Addiction.  115 (2019)  4 - p. 768-777 , 2019
Link: https://doi.org/10.1111/..
 
?
15

Treatment‐resistant depression as risk factor for substance..:

Brenner, Philip ; Brandt, Lena ; Li, Gang...
Addiction.  114 (2019)  7 - p. 1274-1282 , 2019
Link: https://doi.org/10.1111/..
 
1-15